Acadia Healthcare is eyeing further M&A activity and de novo expansion in 2023. With the former, the behavioral health provider anticipates taking advantage of falling valuations as well. Generally, the Tennessee-based Acadia is doubling down on its five-pillar growth strategy. In addition to M&A and de novos, the strategy includes facility expansion, JVs and adding more comprehensive treatment centers for addiction treatment, Behavioral Health Business reports.
“We continue to feel very optimistic about the M&A pipeline, which is clearly one of our important growth levers for 2023,” Chris Hunter, CEO of Acadia, said during the company’s Q4 earnings call. Read more.
